Quadrature Capital Ltd

Position in ABT — Abbott Laboratories

CIK 1651424 LONDON, X0

Position in ABT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$32,362,405

+$22,102,533 QoQ

Shares Held

315,208

+284.9% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.43%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Quadrature Capital Ltd holds $77,742,256 across 9 Medical Devices names. ABT ranks #2 (41.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	670,091	$42,048,210
2	ABT	Abbott Laboratories This page	315,208	$32,362,405
3	SNN	Smith & Nephew PLC	44,730	$1,421,519
4	BWAY	Brainsway Ltd.	76,443	$1,015,927
5	INMD	InMode Ltd.	34,893	$477,336
6	PACB	Pacific Biosciences Of California, Inc.	112,503	$148,503
7	VMD	Viemed Healthcare, Inc.	12,924	$119,030
8	LAB	Standard Biotools Inc.	114,899	$105,707

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$32,362,405	315,208	+284.9%	Shares	Other	2026-05-15
2025-12-31	$10,259,872	81,889	+208.4%	Shares	Other	2026-02-17
2025-09-30	$3,556,107	26,550	-55.7%	Shares	Other	2025-11-13
2024-09-30	$6,828,058	59,890	-41.9%	Shares	Defined	2024-11-14
2024-06-30	$10,702,210	102,995	+410.6%	Shares	Sole	2024-08-14
2023-06-30	$2,199,260	20,173	+187.2%	Shares	Sole	2023-08-14
2022-12-31	$771,274	7,025	-96.2%	Shares	Sole	2023-02-14
2022-09-30	$17,672,730	182,645	+157.2%	Shares	Sole	2022-11-14
2022-06-30	$7,714,150	71,000	+36.6%	Shares	Sole	2022-08-15
2022-03-31	$6,153,773	51,992	+74.5%	Shares	Sole	2022-05-16
2021-12-31	$4,193,489	29,796	+192.7%	Shares	Sole	2022-02-14
2021-03-31	$1,219,971	10,180	-81.0%	Shares	Sole	2021-05-17
2020-12-31	$5,853,992	53,466	+590.1%	Shares	Sole	2021-02-16
2020-03-31	$611,394	7,748	—	Shares	Sole	2024-04-10
No filing history on record for this holder in this stock.